Skip to main content

Table 3 Adjustment of anti-inflammatory treatment by centre

From: Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice

Ā 

Center 1

n = 20

Center 2

n = 21

Center 3

n = 14

Center 4

n = 7

Center 5

n = 8

Center 6

n = 6

Total

n = 76

Corticoids pulse ā€” no./total no. (%)+a

5/20 (25.0)

9/21 (42.9)

9/14 (64.3)

4/5 (80.0)

6/7 (85.7)

6/6 (100)

39/71 (54.9)

Oral corticoids ā€” no./total no. (%)a

15/20 (75.0)

18/20 (90.0)

12/14 (85.7)

3/6 (50.0)

8/8 (100)

6/6 (100)

62/74 (83.8)

Subconjonctival corticoids ā€” no./total no. (%)a

10/19 (52.6)

5/13 (38.5)

9/14 (64.3)

3/3 (100)

6/7 (85.7)

6/6 (100)

39/62 (62.9)

Intracamerular corticoids ā€” no./total no. (%)a

3/19 (15.8)

5/13 (38.5)

1/14 (7.1)

1/3 (33.3)

1/6 (16.7)

0/6 (0.0)

11/61 (18.0)

Corticoids eyedrops ā€” no./total no. (%)a

19/20 (95.0)

10/10 (100)

14/14 (100)

6/6 (100)

6/6 (100)

6/6 (100)

61/62 (98.4)

Discontinuation of immunosuppressive drugs ā€”no./total no. (%)

3/20 (15.0)

0/21 (0.0)

0/14 (0.0)

0/7 (0.0)

2/8 (25.0)

0/6 (0.0)

5/76 (6.6)

  1. aData not available for some patients